相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Paraoxonase-1 Status in Crohn's Disease and Ulcerative Colitis
Dorota Boehm et al.
INFLAMMATORY BOWEL DISEASES (2009)
The paraoxonase gene polymorphism in stroke patients and lipid profile
B. -S. Shin et al.
ACTA NEUROLOGICA SCANDINAVICA (2008)
Serum paraoxonase-1 activity in Helicobacter pylori infected subjects
Mehmet Aslan et al.
ATHEROSCLEROSIS (2008)
Protective effect of paraoxonase-2 against endoplasmic reticulum stress-induced apoptosis is lost upon disturbance of calcium homoeostasis
Sven Horke et al.
BIOCHEMICAL JOURNAL (2008)
Characterization of the PON1 active site using modeling simulation, in relation to PON1 lactonase activity
Hagai Tavori et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Paraoxonase-1 deficiency in mice predisposes to vascular inflammation, oxidative stress, and thrombogenicity in the absence of hyperlipidemia
Dominic S. Ng et al.
CARDIOVASCULAR PATHOLOGY (2008)
Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischernic stroke
Birsen Can Demirdogen et al.
CLINICAL BIOCHEMISTRY (2008)
Advances in laboratory evolution of enzymes
Shimon Bershtein et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2008)
Immunohistochemical analysis of paraoxonases-1, 2, and 3 expression in normal mouse tissues
Judit Marsillach et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Comparison of the ability of paraoxonases 1 and 3 to attenuate the in vitro oxidation of low-density lipoprotein and reduce macrophage oxidative stress
Yifen Liu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Paraoxonase 1 (PON1) attenuates diabetes development in mice through its antioxidative properties
Orit Rozenberg et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Drosophila are protected from Pseudomonas aeruginosa lethality by transgenic expression of paraoxonase-1
David A. Stoltz et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Serum paraoxonase undergoes inhibition and proteolysis during experimental acute pancreatitis
Neus Franco-Pons et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2008)
Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients
LeAnne T. Bloedon et al.
JOURNAL OF LIPID RESEARCH (2008)
Association of paraoxonase gene cluster polymorphisms with ALS in France, Quebec, and Sweden
P. N. Valdmanis et al.
NEUROLOGY (2008)
Paraoxonase 1 (PON1) polymorphisms and prostate cancer in the CPS-II nutrition cohort
Victoria L. Stevens et al.
PROSTATE (2008)
PON1Q192R genetic polymorphism modifies organophosphorous pesticide effects on semen quality and DNA integrity in agricultural workers from southern Mexico
N. Perez-Herrera et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2008)
Lipoprotein inflammatory properties and serum amyloid A levels but not cholesterol levels predict lesion area in cholesterol-fed rabbits
Brian J. Van Lenten et al.
JOURNAL OF LIPID RESEARCH (2007)
Measurement of serum paraoxonase-1 activity as a potential biomarker for chronic liver impairment
Jordi Camps et al.
CLINICA CHIMICA ACTA (2007)
Serum paraoxonase-1 activity and concentration are influenced by human immunodeficiency virus infection
Sandra Parra et al.
ATHEROSCLEROSIS (2007)
Paraoxonases are associated with intestinal inflammatory diseases and intracellularly localized to the endoplasmic reticulum
Lilah Rothem et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
The development of human sera tests for HDL-bound serum PON1 and its lipolactonase activity
Leonid Gaidukov et al.
JOURNAL OF LIPID RESEARCH (2007)
Adenovirus-mediated expression of human paraoxonase 3 protects against the progression of atherosclerosis in apolipoprotein E-deficient mice
Carey J. Ng et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Serum paraoxonase-1 in chronic alcoholics:: Relationship with liver disease
Judit Marsillach et al.
CLINICAL BIOCHEMISTRY (2007)
High-density lipoprotein attenuates inflammation and coagulation response on endotoxin challenge in humans
Rakesh S. Birjmohun et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Estrogen esters as substrates for human paraoxonases
John F. Teiber et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2007)
Peptide mimetics of apolipoproteins improve HDL function
Mohamad Navab et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2007)
Decreased obesity and atherosclerosis in human paraoxonase 3 transgenic mice
Diana M. Shih et al.
CIRCULATION RESEARCH (2007)
Paraoxonase-2 reduces oxidative stress in vascular cells and decreases endoplasmic reticulum stress-induced caspase activation
Sven Horke et al.
CIRCULATION (2007)
Administration of exogenous erythropoietin β affects lipid peroxidation and serum paraoxonase-1 activity and concentration in predialysis patients with chronic renal disease and anaemia
Judit Marsillach et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2007)
Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population
Emin T. Elkiran et al.
BMC CANCER (2007)
Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptides
G. M. Anantharamaiah et al.
JOURNAL OF LIPID RESEARCH (2007)
S-Glutathionylation regulates HDL-associated paraoxonase 1 (PON1) activity
Orit Rozenberg et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Adenovirus mediated expression of human paraoxonase 2 protects against the development of atherosclerosis in apolipoprotein E-deficient mice
Carey J. Ng et al.
MOLECULAR GENETICS AND METABOLISM (2006)
Defective metabolism of oxidized phospholipid by HDL from people with type 2 diabetes
Maria Mastorikou et al.
DIABETES (2006)
The 192R/Q polymorphs of serum paraoxonase PON1 differ in HDL binding, lipolactonase stimulation, and cholesterol efflux
Leonid Gaidukov et al.
JOURNAL OF LIPID RESEARCH (2006)
Paraoxonase-2 deficiency aggravates atherosclerosis in mice despite lower apolipoprotein-B-containing lipoproteins - Anti-atherogenic role for paraoxonase-2
Carey J. Ng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Antioxidant and cytoprotective properties of high-density lipoproteins in vascular cells
Anne Negre-Salvayre et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
Enzyme promiscuity: evolutionary and mechanistic aspects
Olga Khersonsky et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2006)
Paraoxonase cluster polymorphisms are associated with sporadic ALS
M. Saeed et al.
NEUROLOGY (2006)
Paraoxonase gene polymorphisms and sporadic ALS
A. Slowik et al.
NEUROLOGY (2006)
RP-HPLC determination of paraoxonase 3 activity in human blood serum
Zofia Suchocka et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2006)
Paraoxonase-1 expression is up-regulated in Down syndrome fetal liver
Nathalle Janel et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Reciprocal and coordinate regulation of serum amyloid A versus apolipoprotein A-I and paraoxonase-1 by inflammation in murine hepatocytes
Chang Yeop Han et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Human paraoxonase-1 overexpression inhibits atherosclerosis in a mouse model of metabolic syndrome
Bharti Mackness et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Directed evolution: An approach to engineer enzymes
Jasjeet Kaur et al.
CRITICAL REVIEWS IN BIOTECHNOLOGY (2006)
Dietary antioxidants in preventing atherogenesis
A. C. Kaliora et al.
ATHEROSCLEROSIS (2006)
Paraoxonase-1 is associated with oxidative stress, fibrosis and FAS expression in chronic liver diseases
Natalia Ferre et al.
JOURNAL OF HEPATOLOGY (2006)
Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy
Giada Sebastiani et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Relationship of serum paraoxonase 1 activity and paraoxonase 1 genotype to risk of systemic lupus erythematosus
Laura M. Tripi et al.
ARTHRITIS AND RHEUMATISM (2006)
HIV-infected patients with lipodystrophy have higher rates of carotid atherosclerosis:: The role of monocyte chemoattractant protein-1
Blai Coll et al.
CYTOKINE (2006)
The histidine 115-histidine 134 dyad mediates the lactonase activity of mammalian serum paraoxonases
O Khersonsky et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The catalytic histidine dyad of high density lipoprotein-associated serum paraoxonase-1 (PON1) is essential for PON1-mediated inhibition of low density lipoprotein oxidation and stimulation of macrophage cholesterol efflux
M Rosenblat et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Age-related decrease in high-density lipoproteins antioxidant activity is due to an alteration in the PON1's free sulfhydyl groups
L Jaouad et al.
ATHEROSCLEROSIS (2006)
Polymorphisms in the PON gene cluster are associated with Alzheimer disease
PM Erlich et al.
HUMAN MOLECULAR GENETICS (2006)
Association of polymorphisms in the paraoxonase 1 gene with breast cancer incidence in the CPS-II nutrition cohort
Victoria L. Stevens et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Directed evolution of enzymes and biosynthetic pathways
Tyler W. Johannes et al.
CURRENT OPINION IN MICROBIOLOGY (2006)
Mechanisms of disease: proatherogenic HDL - an evolving field
Mohamad Navab et al.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2006)
HIV infection and high-density lipoprotein: the effect of the disease vs the effect of treatment
H Rose et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2006)
Chromogenic and fluorogenic assays for the lactonase activity of serum paraoxonases
O Khersonsky et al.
CHEMBIOCHEM (2006)
A long and winding road: defining the biological role and clinical importance of paraoxonases
Richard W. James
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2006)
Serum arylesterase and paraoxonase activity in patients with chronic hepatitis
Suleyman Sirri Kilic et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Human and murine paraoxonase 1 are host modulators of Pseudomonas aeruginosa quorum-sensing
EA Ozer et al.
FEMS MICROBIOLOGY LETTERS (2005)
Increased levels of lipid hydroperoxides in plasma of patients with multiple sclerosis: a relationship with paraoxonase activity
G Ferretti et al.
MULTIPLE SCLEROSIS JOURNAL (2005)
High-throughput screening of enzyme libraries: Thiolactonases evolved by fluorescence-activated sorting of single cells in emulsion compartments
A Aharoni et al.
CHEMISTRY & BIOLOGY (2005)
High-density lipoprotein function - Recent advances
BJ Ansell et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
The stromal derived factor-1 mutated allele (SDF1-3′A,) is associated with a lower incidence of atherosclerosis in HIV-infected patients
B Coll et al.
AIDS (2005)
Genetic association of paraoxonase-1 polymorphisms and chronic hepatitis C virus infection
N Ferré et al.
CLINICA CHIMICA ACTA (2005)
Increased atherosclerosis in mice lacking apolipoprotein A-I attributable to both impaired reverse cholesterol transport and increased inflammation
RE Moore et al.
CIRCULATION RESEARCH (2005)
Oral small peptides render HDL antiinflammatory in mice and monkeys and reduce atherosclerosis in ApoE null mice
M Navab et al.
CIRCULATION RESEARCH (2005)
Paraoxonases (PONs) 1, 2, and 3 are expressed in human and mouse gastrointestinal tract and in Caco-2 cell line: Selective secretion of PON1 and PON2
R Shamir et al.
FREE RADICAL BIOLOGY AND MEDICINE (2005)
Toxicity of chlorpyrifos and chlorpyrifos oxon in a transgenic mouse model of the human paraoxonase (PON1) Q192R polymorphism
TB Cole et al.
PHARMACOGENETICS AND GENOMICS (2005)
Responsiveness to cholinesterase inhibitors in Alzheimer's disease: A possible role for the 192 Q/R polymorphism of the PON-1 gene
R Pola et al.
NEUROSCIENCE LETTERS (2005)
Amyloid-β in Alzheimer's disease:: the horse or the cart?: Pathogenic or protective?
HG Lee et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2005)
Oxidative stress and high-density lipoprotein function in Type I diabetes and end-stage renal disease
G Kalogerakis et al.
CLINICAL SCIENCE (2005)
Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities
DI Draganov et al.
JOURNAL OF LIPID RESEARCH (2005)
Comparison of paraoxonase 1 measurements in serum and in lithium-heparin-anticoagulated plasma samples
N Ferré et al.
CLINICAL CHEMISTRY (2005)
Structure-reactivity studies of serum paraoxonase PON1 suggest that its native activity is lactonase
O Khersonsky et al.
BIOCHEMISTRY (2005)
The clinical syndrome of Alzheimer's disease: aspects particularly relevant to clinical trials
RC Mohs
GENES BRAIN AND BEHAVIOR (2005)
Enhancing catalytic promiscuity for biocatalysis
RJ Kazlauskas
CURRENT OPINION IN CHEMICAL BIOLOGY (2005)
Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: a possible role for lysophosphatidylcholine
M Rosenblat et al.
ATHEROSCLEROSIS (2005)
Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease?
A Chait et al.
JOURNAL OF LIPID RESEARCH (2005)
Modulation of paraoxonase (PON1) activity
LG Costa et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Measurement of paraoxonase (PON1) status as a potential biomarker of susceptibility to organophosphate toxicity
LG Costa et al.
CLINICA CHIMICA ACTA (2005)
The paraoxonase gene family and atherosclerosis
CJ Ng et al.
FREE RADICAL BIOLOGY AND MEDICINE (2005)
Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes
M Harel et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2004)
Four paraoxonase gene polymorphisms in 11,212 cases of coronary heart disease and 12,786 controls: meta-analysis of 43 studies
JG Wheeler et al.
LANCET (2004)
Directed evolution of mammalian paraoxonases PON1 and PON3 for bacterial expression and catalytic specialization
A Aharoni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Possible association between Cys311Ser polymorphism of paraoxonase 2 gene and late-onset Alzheimer's disease in Chinese
JJ Shi et al.
MOLECULAR BRAIN RESEARCH (2004)
Paraoxonase 1 (PON1) gene polymorphisms and Parkinson's disease in a Finnish population
J Clarimon et al.
NEUROSCIENCE LETTERS (2004)
Paraoxonase polymorphisms and coronary heart disease
PN Durrington et al.
LANCET (2004)
Purified human serum PON1 does not protect LDL against oxidation in the in vitro assays initiated with copper or AAPH
JF Teiber et al.
JOURNAL OF LIPID RESEARCH (2004)
Distribution spectrum of paraoxonase activity in HDL fractions
C Bergmeier et al.
CLINICAL CHEMISTRY (2004)
Visualization and mechanical manipulations of individual fibrin fibers suggest that fiber cross section has fractal dimension 1.3
M Guthold et al.
BIOPHYSICAL JOURNAL (2004)
Atherosclerosis, vascular amyloidosis and brain hypoperfusion in the pathogenesis of sporadic Alzheimer's disease
W Kalback et al.
NEUROLOGICAL RESEARCH (2004)
Weight loss-associated induction of peroxisome proliferator-activated receptor-α and peroxisome proliferator-activated receptor-γ correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice
W Verreth et al.
CIRCULATION (2004)
Oral D-4F causes formation of pre-β high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice
M Navab et al.
CIRCULATION (2004)
Paraoxonase-1 inhibits oxidised LDL-induced MCP-1 production by endothelial cells
B Mackness et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cells
E Zamara et al.
JOURNAL OF HEPATOLOGY (2004)
Atherosclerosis of cerebral arteries in Alzheimer disease
AE Roher et al.
STROKE (2004)
Catalytic promiscuity in biocatalysis: Using old enzymes to form new bonds and follow new pathways
UT Bornscheuer et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2004)
The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL
M Navab et al.
JOURNAL OF LIPID RESEARCH (2004)
Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development
M Aviram et al.
FREE RADICAL BIOLOGY AND MEDICINE (2004)
Genetic and environmental factors modulating serum concentrations and activities of the antioxidant enzyme paraoxonase-1
SP Deakin et al.
CLINICAL SCIENCE (2004)
Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties -: A new mechanism linking HDL protein composition and antiatherogenic potential
V Ribas et al.
CIRCULATION RESEARCH (2004)
Association of paraoxonase 1 gene polymorphisms with risk of Parkinson's disease: a meta-analysis
E Zintzaras et al.
JOURNAL OF HUMAN GENETICS (2004)
Pharmacotherapeutic approaches to the treatment of Alzheimer's disease
JB Standridge
CLINICAL THERAPEUTICS (2004)
Light, but not heavy alcohol drinking, stimulates paraoxonase by upregulating liver mRNA in rats and humans
MN Rao et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2003)
Lactonase and lactonizing activities of human serum paraoxonase (PON1) and rabbit serum PON3
JF Teiber et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Lipid rafts and HIV pathogenesis: Virion-associated cholesterol is required for fusion and infection of susceptible cells
ZH Liao et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2003)
Low paraoxonase activity predicts coronary events in the caerphilly prospective study
B Mackness et al.
CIRCULATION (2003)
Serum paraoxonase: effect of the apolipoprotein composition of HDL and the acute phase response
VG Cabana et al.
JOURNAL OF LIPID RESEARCH (2003)
Expression of major HDL-associated antioxidant PON-1 is gender dependent and regulated during inflammation
A Bin Ali et al.
FREE RADICAL BIOLOGY AND MEDICINE (2003)
Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice - LCAT gene transfer decreases atherosclerosis
A Mertens et al.
CIRCULATION (2003)
Enzymes with extra talents: moonlighting functions and catalytic promiscuity
SD Copley
CURRENT OPINION IN CHEMICAL BIOLOGY (2003)
Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: Studies in PON1-knockout mice
O Rozenberg et al.
FREE RADICAL BIOLOGY AND MEDICINE (2003)
Different pattern of association of paraoxonase Gln192→Arg polymorphism with sporadic late-onset Alzheimer's disease and coronary artery disease
R Scacchi et al.
NEUROSCIENCE LETTERS (2003)
Mouse macrophage paraoxonase 2 activity is increased whereas cellular paraoxonase 3 activity is decreased under oxidative stress
M Rosenblat et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Platelet-activating factor acetylhydrolase, and not paraoxonase-1, is the oxidized phospholipid hydrolase of high density lipoprotein particles
GK Marathe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The effect of high-density lipoproteins on the formation of lipid/protein conjugates during in vitro oxidation of low-density lipoprotein
P Sangvanich et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Vascular pathology in Alzheimer disease: Correlation of cerebral amyloid angiopathy and arteriosclerosis/lipohyalinosis with cognitive decline
DR Thal et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)
Atherosclerosis, oxidative stress and auto-antibodies in systemic lupus erythematosus and primary antiphospholipid syndrome
JD Alves et al.
IMMUNOBIOLOGY (2003)
Lack of association between Alzheimer's disease and Gln-Arg 192 Q/R polymorphism of the PON-1 gene in an Italian population
R Pola et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2003)
Paraoxonase gene polymorphisms, oxidative stress, and diseases
HL Li et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2003)
Vitamin C and E intake is associated with increased paraoxonase activity
GP Jarvik et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice
A Tward et al.
CIRCULATION (2002)
Further evidence for an association of the paraoxonase 1 (PON1) Met-54 allele with Parkinson's disease
A Carmine et al.
MOVEMENT DISORDERS (2002)
Paraoxonase Gln-Arg(192) and Leu-Met(55) gene polymorphisms and enzyme activity in a population with a low rate of coronary heart disease
N Ferré et al.
CLINICAL BIOCHEMISTRY (2002)
Elevated soluble cellular adhesion molecules in subjects with low HDL-cholesterol
L Calabresi et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia
G Paragh et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2002)
Paraoxonase 1 overexpression in mice and its effect on high-density lipoproteins
MN Oda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
HDL and arteriosclerosis: beyond reverse cholesterol transport
JR Nofer et al.
ATHEROSCLEROSIS (2002)
Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein
CJ Ng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Glycated high-density lipoprotein induces apoptosis of endothelial cells via a mitochondrial dysfunction
T Matsunaga et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Paraoxonase status in coronary heart disease - Are activity and concentration more important than genotype?
B Mackness et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
The paraoxonase PON1 promoter polymorphism C(-107)T is associated with increased serum glucose concentrations in non-diabetic patients
I Leviev et al.
DIABETOLOGIA (2001)
Hepatic paraoxonase activity alterations and free radical production in rats with experimental cirrhosis
N Ferré et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2001)
High density lipoproteins reduce organ injury and organ dysfunction in a rat model of hemorrhagic shock
GW Cockerill et al.
FASEB JOURNAL (2001)
Immunohistochemical evidence for the expression and induction of paraoxonase in rat liver, kidney, lung and brain tissue.: implications for its physiological role
L Rodrigo et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2001)
Apolipoprotein A-I promotes the formation of phosphatidylcholine core aldehydes that are hydrolyzed by paraoxonase (PON-1) during high density lipoprotein oxidation with a peroxynitrite donor
Z Ahmed et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Time sequence of the inhibition of endothelial adhesion molecule expression by reconstituted high density lipoproteins
MA Clay et al.
ATHEROSCLEROSIS (2001)
Genetic polymorphisms in older subjects with vascular or Alzheimer's dementia
G Zuliani et al.
ACTA NEUROLOGICA SCANDINAVICA (2001)
Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids
ST Reddy et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
HDL and the inflammatory response induced by LDL-derived oxidized phospholipids
M Navab et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Paraoxonase 1 Met-Leu 54 polymorphism is associated with Parkinson's disease
SN Akhmedova et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2001)
Polymorphisms in the human paraoxonase (PON1) promoter
VH Brophy et al.
PHARMACOGENETICS (2001)
Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds
WF Li et al.
PHARMACOGENETICS (2000)
Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1192 or PON155 genotype
GP Jarvik et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation
DI Draganov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
How high-density lipoprotein protects against the effects of lipid peroxidation
MI Mackness et al.
CURRENT OPINION IN LIPIDOLOGY (2000)
Promoter polymorphism T(-107)C of the paraoxonase PON1 gene is a risk factor for coronary heart disease in type 2 diabetic patients
RW James et al.
DIABETES (2000)
High-density lipoproteins protect endothelial cells from tumor necrosis factor-α-induced apoptosis
M Sugano et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis
DM Shih et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Infection and inflammation-induced proatherogenic changes of lipoproteins
W Khovidhunkit et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions - PON1 esterase and peroxidase-like activities
M Aviram et al.
CIRCULATION (2000)
Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts
DH Nguyen et al.
JOURNAL OF VIROLOGY (2000)
Calcium-dependent human serum homocysteine thiolactone hydrolase -: A protective mechanism against protein N-homocysteinylation
H Jakubowski
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations
I Leviev et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Selective plasma hydrolysis of glucocorticoid γ-lactones and cyclic carbonates by the enzyme paraoxonase:: An ideal plasma inactivation mechanism
K Biggadike et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
分享论文
